OHI and DHG PHARMA have successfully upgraded their non-betalactam drug manufacturing plant to meet EU-GMP standards
Monday, 18 November 2024
Orioled Hub Institute of Pharmaceutical Technologies (OHI) has successfully collaborated with Hau Giang Pharma Joint Stock Company (DHG Pharma) to upgrade DHG Pharma’s non-betalactam drug manufacturing plant to meet EU-GMP standards. The successful project has contributed to enhancing the competitiveness of pharmaceuticals manufactured by Vietnam’s leading pharmaceutical company on the international market. Over the past
- Published in event